AERIE PHARMACEUTICALS INC's ticker is and the CUSIP is 00771VAB4. A total of 19 filers reported holding AERIE PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $17,424,000 | +134.8% | 17,738,000 | +104.0% | 0.67% | +126.0% |
Q2 2022 | $7,420,000 | -4.3% | 8,696,000 | 0.0% | 0.30% | +22.8% |
Q1 2022 | $7,756,000 | -14.2% | 8,696,000 | -19.7% | 0.24% | -14.2% |
Q4 2021 | $9,038,000 | +164.0% | 10,824,000 | +192.5% | 0.28% | +175.5% |
Q3 2021 | $3,423,000 | +54.7% | 3,700,000 | +68.2% | 0.10% | +54.5% |
Q2 2021 | $2,213,000 | – | 2,200,000 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Birch Grove Capital LP | 9,100,000 | $8,937,000 | 3.49% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 174,372,000 | $170,826,000 | 3.40% |
PFM Health Sciences, LP | 48,150,000 | $47,381,000 | 1.71% |
DeepCurrents Investment Group LLC | 17,738,000 | $17,424,000 | 0.67% |
Weiss Asset Management LP | 17,595,000 | $17,263,000 | 0.42% |
DAFNA Capital Management LLC | 1,500,000 | $1,476,000 | 0.40% |
Westchester Capital Management, LLC | 3,853,000 | $3,792,000 | 0.11% |
Calamos Advisors LLC | 15,438,000 | $15,147,000 | 0.07% |
Verition Fund Management LLC | 10,316,000 | $5,081,076 | 0.06% |
OAKTREE CAPITAL MANAGEMENT LP | 2,532,000 | $2,491,000 | 0.03% |